Indication of a potential functional impact of differential γc expression is provided by pSTAT5 analyses and identification of higher IL-2 (partly IL-15) sensitivity in a subset of CD4+ T-cells from T1D patients characterized by high γc expression. This evidence concerns the gene CD4 and type 1 diabetes mellitus.